Professor Simak Ali is investigating how changes in the oestrogen receptor (ER) gene contribute to hormone therapy resistance. He hopes this will lead to more effective treatments for secondary ER-positive breast cancer.  

Dr Robert Kerrison is finding out whether inequalities in breast cancer have gotten worse since the start of the COVID-19 pandemic.

Dr Sankari Nagarajan is investigating how some triple negative breast cancers spread to other parts of the body. And she wants to see if drugs against proteins called nuclear receptors could stop this from happening.

Dr Christian Zierhut and his team are testing whether boosting the immune system during treatment with drugs called PARP inhibitors makes it more effective.

Professor Penelope Ottewell and her PhD student are testing new combinations of drugs to treat breast cancer that’s spread to the bone. They’re hoping that this work could be the foundation of new treatment options for secondary breast cancer.

Professor Robert Horne and Dr Zoe Moon are investigating what black women think about their breast cancer treatment and care in the UK. In particular, what they think about taking hormone therapy. They want to find ways to better support black women and reduce health inequalities.